Induction of cyclo-oxygenase-2 expression in naturally occurring gastric ulcers

被引:6
|
作者
Lajoie, S
Sirois, J
Doré, M
机构
[1] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada
[2] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada
关键词
cyclo-oxygenase-2; gastric ulcers; pigs; stomach;
D O I
10.1177/002215540205000706
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cyclo-oxygenase-2 (COX-2) is believed to participate in the repair of gastric ulcer. Like humans, pigs frequently develop gastric ulcers and thus represent an attractive animal model in which to study the repair process of naturally occurring gastric ulcers. However, expression of COX in the pig stomach has not been reported. The objectives of this study were to determine whether COX isoenzymes are expressed in porcine gastric ulcers and to characterize the porcine COX-2 cDNA. Normal stomachs (n=5) and those with gastric ulcers (n=35) were studied by immunohistochemistry and immunoblotting analysis. Reverse transcription-polymerase chain reaction (RT-PCR) was used to isolate the complete porcine COX-2 cDNA. COX-1 staining was present in normal stomach and in ulcerated areas. No COX-2 was detected in normal stomach, but COX-2 was strongly expressed in the ulcerated area in 28/35 (80%) gastric ulcers (p<0.01). Immunoblotting analysis confirmed the restricted expression of COX-2 in the ulcerated areas. The porcine COX-2 cDNA was shown to code for a 604 amino acid protein that is 89% identical to human COX-2. These results provide the complete primary structure of porcine COX-2 and demonstrate for the first time that the enzyme is induced in naturally occurring porcine gastric ulcers.
引用
收藏
页码:923 / 933
页数:11
相关论文
共 50 条
  • [21] Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis
    Yu, Jun
    Hui, Alex Y.
    Chu, Eagle S. H.
    Cheng, Alfred S. L.
    Go, Minnie Y. Y.
    Chan, Henry L. Y.
    Leung, Wai K.
    Cheung, Kin F.
    Ching, Arthur K. K.
    Chui, Yiu L.
    Chan, Ka K.
    Sung, Joseph J. Y.
    GUT, 2007, 56 (07) : 991 - 999
  • [22] Clinical Potential of Cyclo-Oxygenase-2 Inhibitors
    Jaime A. Oviedo
    M. Michael Wolfe
    BioDrugs, 2001, 15 : 563 - 572
  • [23] Cyclo-oxygenase-2 inhibitors and cardiovascular events
    Warner, TD
    Mitchell, JA
    Vane, JR
    LANCET, 2002, 360 (9346): : 1700 - 1701
  • [24] INVOLVEMENT OF TYROSINE KINASES IN THE INDUCTION OF CYCLO-OXYGENASE-2 IN HUMAN ENDOTHELIAL CELLS
    BLANCO, A
    HABIB, A
    LEVYTOLEDANO, S
    MACLOUF, J
    BIOCHEMICAL JOURNAL, 1995, 312 : 419 - 423
  • [25] Assessment of 15-HETE production by cyclo-oxygenase-2 in gastric mucosa
    Byrne, MF
    Harhen, B
    Fitzgerald, DJ
    Murray, FE
    GASTROENTEROLOGY, 1999, 116 (04) : A130 - A131
  • [26] STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE
    APPLEBY, SB
    RISTIMAKI, A
    NEILSON, K
    NARKO, K
    HLA, T
    BIOCHEMICAL JOURNAL, 1994, 302 : 723 - 727
  • [27] POLYMORPHISMS IN TWO REGIONS OF THE CYCLO-OXYGENASE-2 GENE ASSOCIATED WITH VARIATION IN RISK OF CORONARY THROMBOSIS WITH CYCLO-OXYGENASE-2 INHIBITORS
    Henry, D.
    Lincz, L.
    Attia, J.
    McElduff, P.
    Bisset, L.
    Peel, R.
    Hancock, S.
    Henderson, K.
    Whitaker, D.
    Seldon, M.
    McGettigan, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 39 - 39
  • [28] Polymorphisms in Two Regions of the Cyclo-Oxygenase-2 Gene Associated with Variation in Risk of Coronary Thrombosis with Cyclo-Oxygenase-2 Inhibitors
    Henry, D.
    Lincz, L.
    Attia, J.
    McElduff, P.
    Bisset, L.
    Peel, R.
    Hancock, S.
    Henderson, K.
    Whitaker, D.
    Seldon, M.
    McGettigan, P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S116 - S116
  • [29] The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene
    McGettigan, Patricia
    Lincz, Lisa F.
    Attia, John
    McElduff, Patrick
    Bissett, Linda
    Peel, Roseanne
    Stokes, Barrie
    Hancock, Stephen
    Henderson, Kim
    Seldon, Michael
    Henry, David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (04) : 707 - 714
  • [30] Clinical potential of cyclo-oxygenase-2 inhibitors
    Oviedo, JA
    Wolfe, MM
    BIODRUGS, 2001, 15 (09) : 563 - 572